Biotechnology

New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...

2019-11-27 02:31 559

Japan and Singapore Grant CRISPR Patents to Merck

- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...

2019-11-26 21:00 420

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 582

USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November

TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...

2019-11-25 15:58 558

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 1097

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2019-11-21 20:00 4326

Global Cord Blood Corp Comments on New Regulation

HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...

2019-11-20 20:00 3898

RhoVac Reports Interim Results on Immunological Response with RV001

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...

2019-11-18 17:13 455

Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People

BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'sile...

2019-11-17 12:00 1040

World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers

* Phase 1A/1B safety and efficacy trials in Singapore completed within 8 months * TY014 also found to prevent vaccine related adverse effects in vaccinated volunteers SINGAPORE, Nov. 14, 2019 /PRNewswire/ -- Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF)...

2019-11-14 11:07 599

Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner

VISTA, Calif., Nov. 14, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading ...

2019-11-14 08:00 523

Merck Licenses CRISPR Gene-Editing Technology to Evotec

-- License to accelerate research, enable testing and development of new drugs DARMSTADT, Germany, Nov. 12, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingEvotec SE access to Merck's foundational CRISPR intelle...

2019-11-12 21:00 636

Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens , a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP campaign on Indiegogo. The device follows the success of the Company's fir...

2019-11-12 20:18 567

AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

SEATTLE, Nov. 12, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at theirSeattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of...

2019-11-12 20:00 495

ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders

BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, andCyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery proce...

2019-11-11 21:45 555

Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director

HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...

2019-11-11 19:30 3219

Akeso, Inc. Completes Series-D Private Financing for US$150 Million

ZHONGSHAN, China, Nov. 9, 2019 /PRNewswire/ -- Akeso, Inc. (hereinafter referred to as "Akeso") announced the completion of its Series-D private financing for nearlyUS$150 million, which was co-led in investment by Loyal Valley Capital ("LVC") and Sino Biopharmaceutical Co. Ltd. ("Sino Biopharm")...

2019-11-09 00:43 1506

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

MADISON, Wisconsin, Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed itspreviously announced combination with Genomic Health, Inc. (NASDAQ: GHDX). "Today marks a pivotal step toward building the world's leading advanced cancer diagnostics co...

2019-11-08 21:24 5794

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 21:02 669

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...

2019-11-07 19:04 5571
12345678 ... 57